Sponsored by:

Duke MMIL designs novel SPECT/CT system for 3D breast imaging

Jul 17, 2007
2007 07 17 15 08 50 706
2007 07 17 15 08 50 706
Image courtesy of Duke University Medical Center Multi-Modality Imaging Lab.

close

Latest in Molecular Imaging
Rsna Mahmood Thumbnail 675376af1d42d
Stanford Medicine appoints Umar Mahmood chair of radiology
August 29, 2025
Your faster way to answers with Symbia Pro.specta
Sponsored
Your faster way to answers with Symbia Pro.specta
August 1, 2025
Ame 2018 12 11 00 02 7009 Atom Nuclear Lab 400
FDA rejects Telix's BLA for kidney cancer investigational PET agent
August 29, 2025
Breast Cancer
Experts issue appropriate use criteria for molecular breast imaging
August 27, 2025
Related Stories
2007 07 17 14 38 39 706
Molecular Imaging
Duke MMIL designs novel SPECT/CT system for 3D breast imaging
2007 07 17 14 32 28 706
Molecular Imaging
Duke MMIL designs novel SPECT/CT system for 3D breast imaging
2007 06 25 10 54 15 706
Molecular Imaging
Studies link Alzheimer's to beta-amyloid and potential for new ligand
Your faster way to answers with Symbia Pro.specta
Sponsor Content
Your faster way to answers with Symbia Pro.specta
More in Molecular Imaging
Stanford Medicine appoints Umar Mahmood chair of radiology
By AuntMinnie.com staff writers
Mahmood's appointment follows a national search.
August 29, 2025
Rsna Mahmood Thumbnail 675376af1d42d
PET/MR enterography shows promise in Crohn’s disease
By Will Morton
F-18 FDG-PET/MRE appears valuable not only for diagnosing small bowel Crohn’s disease but also for monitoring treatment responses.
August 29, 2025
2025 08 29 Crohns Mre Thumbnail
FDA rejects Telix's BLA for kidney cancer investigational PET agent
By AuntMinnie.com staff writers
The U.S. FDA has requested additional data from Telix for its biologics license application (BLA) regarding its TLX250-CDx PET agent.
August 29, 2025
Ame 2018 12 11 00 02 7009 Atom Nuclear Lab 400
Experts issue appropriate use criteria for molecular breast imaging
By Will Morton
The criteria offer use scenarios for technetium-99 (Tc-99m) sestamibi-based gamma camera imaging of the breast.
August 27, 2025
Breast Cancer
Brightonix gets FDA nod for PET scanner
By AuntMinnie.com staff writers
The scanner converts to both lying and seated modes for brain imaging.
August 27, 2025
Brightonix's PHAROS PET scanner.
PET links brain receptor to emotional numbing in PTSD
By Will Morton
To date, only a single study has investigated CB1R availability in humans exposed to trauma.
August 25, 2025
Ad
Radiopharmaceutical production gets boost from radium transfers to U.S.
By AuntMinnie.com staff writers
Legacy sources will significantly add to actinium-225 (Ac-225) production.
August 22, 2025
Ame 2018 12 11 00 02 7009 Atom Nuclear Lab 400
Nusano opens flagship radioisotope production facility in Utah
By AuntMinnie.com staff writers
The facility will support domestic radiopharmaceutical manufacturing.
August 22, 2025
Wvc Flyover Oct 2024 Nusano Pr
AI model shows promise for diagnosing prostate cancer
By Will Morton
The sensitivity of the model was comparable to that of nuclear medicine physicians.
August 22, 2025
Psma Pet
SNMMI praises Senate for including nuclear medicine language in reports
By AuntMinnie.com staff writers
The SNMMI is lauding the Senate Appropriations Committee for including nuclear medicine research language in its 2026 fiscal reports.
August 21, 2025
Atom Nuclear
FES-PET shows promise staging women with invasive lobular cancer
By Will Morton
Invasive lobular cancer is the second most common type of breast cancer and is difficult to detect, but FES-PET could aid in surgical staging.
August 20, 2025
A 58-year-old woman was diagnosed with ER-positive (Allred score 8) ILC in her right breast. Ultrasound and MRI found prominent lymph nodes in right axillary level I area, diagnosed as metastasis on ultrasound-guided fine-needle aspiration. F-18 FES-PET/CT showed a positive mass in right breast (white arrow; SUVmax, 5.6) and multiple F-18 FES–positive lymph nodes in right axillary level I, II, and II/III junction areas (red arrows; SUVmax, up to 12.2). In addition, a small F-18 FES-positive lymph node was observed in the right second internal mammary area (red circles; SUVmax, 1.8). However, biopsy could not be performed because it was too small and not visible on ultrasound; the clinician decided to include internal mammary lymph node in treatment field for adjuvant radiotherapy. The patient underwent lumpectomy with ALN dissection, with five metastases being identified in 13 lymph nodes dissected, and is scheduled to receive adjuvant chemotherapy, radiotherapy, and endocrine therapy.
PET/CT identifies bone demineralization in breast cancer patients
By Will Morton
PET/CT holds promise as an opportunistic osteoporosis screening tool in high-risk oncology subgroups.
August 14, 2025
Patient Pet
Page 1 of 612
Next Page